Protein C, antithrombin, and venous thromboembolism incidence: A prospective population-based study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 6, 2002, Pages 1018-1022

  Folsom, Aaron R ^a   Aleksic, Nena ^a   Wang, Lu ^a   Cushman, Mary ^a   Wu, Kenneth K ^a   White, Richard H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antithrombin; Prospective study; Protein C; Pulmonary embolus; Venous thrombosis

Indexed keywords

ANTITHROMBIN; PROTEIN C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; ARTERIOSCLEROSIS; COHORT STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MIDDLE AGED; ODDS RATIO; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN C DEFICIENCY; PULMONARY EMBOLISM; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0036072240     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000017470.08363.AB     Document Type: Article

References (25)

1. Inherited thrombophilia: Part 1
2. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
3. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis
4. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism: Results of the Spanish Multicentric Study on Thrombophilia (EMET-Study)
5. Prevalence of protein C deficiency in the healthy population
6. Absence of thrombosis in subjects with heterozygous protein C deficiency
7. Prevalence of antithrombin deficiency in the healthy population
8. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
9. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study
10. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: A multicenter collaborative family study
11. Incidence of venous thromboembolism in families with inherited thrombophilia
12. Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
13. Antithrombin III: Associations with age, race, sex and cardiovascular disease risk factors
14. Risk factors for venous thrombotic disease
15. Cardiovascular risk factors and venous thromboembolism incidence: The Longitudinal Investigation of Thromboembolism Etiology (LITE) Study
16. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors
17. Short-term intra-individual variability in hemostasis factors: The ARIC Study
18. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition
19. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
20. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
21. Dose-response and trend analysis in epidemiology: Alternatives to categorical analysis
22. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
23. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency
24. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years: Relationships to hormone replacement therapy